Pulike Biological Engineering
Pulike Biological Engineering, Inc. engages in the research, development, production, and sale of veterinary biological products, chemical drugs, and traditional Chinese veterinary drugs. The company offers vaccines, antibodies, and medicines for swine and poultry, as well as disinfectants. Pulike Biological Engineering, Inc. was founded in 1995 and is headquartered in Luoyang, China.
Pulike Biological Engineering (603566) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.034x
Based on the latest financial reports, Pulike Biological Engineering (603566) has a cash flow conversion efficiency ratio of 0.034x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥87.38 Million) by net assets (CN¥2.58 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Pulike Biological Engineering - Cash Flow Conversion Efficiency Trend (2010–2024)
This chart illustrates how Pulike Biological Engineering's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Pulike Biological Engineering Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pulike Biological Engineering ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenzhen Phoenix Telecom Technology Co. Ltd.
SHE:301191
|
0.100x |
|
Rigol Technologies Co. Ltd. A
SHG:688337
|
N/A |
|
SDIC Zhonglu Fruit Juice Co Ltd
SHG:600962
|
-0.017x |
|
TPK Holding Co Ltd
TW:3673
|
-0.015x |
|
Jiangsu Xiuqiang Glasswork Co
SHE:300160
|
0.031x |
|
J.Pond Precision Technology Co. Ltd. A
SHE:301326
|
N/A |
|
BizConf Telecom Co Ltd
SHE:300578
|
0.003x |
|
Changchai Co Ltd
SHE:000570
|
-0.037x |
Annual Cash Flow Conversion Efficiency for Pulike Biological Engineering (2010–2024)
The table below shows the annual cash flow conversion efficiency of Pulike Biological Engineering from 2010 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.63 Billion | CN¥268.79 Million | 0.102x | -1.41% |
| 2023-12-31 | CN¥2.72 Billion | CN¥282.78 Million | 0.104x | +27.22% |
| 2022-12-31 | CN¥2.80 Billion | CN¥228.36 Million | 0.082x | -30.87% |
| 2021-12-31 | CN¥1.80 Billion | CN¥212.53 Million | 0.118x | -22.92% |
| 2020-12-31 | CN¥1.71 Billion | CN¥261.83 Million | 0.153x | +81.24% |
| 2019-12-31 | CN¥1.66 Billion | CN¥140.10 Million | 0.084x | +9.45% |
| 2018-12-31 | CN¥1.64 Billion | CN¥126.27 Million | 0.077x | -14.02% |
| 2017-12-31 | CN¥1.57 Billion | CN¥140.86 Million | 0.090x | -47.45% |
| 2016-12-31 | CN¥1.48 Billion | CN¥253.03 Million | 0.171x | +22.12% |
| 2015-12-31 | CN¥1.34 Billion | CN¥187.09 Million | 0.140x | -36.75% |
| 2014-12-31 | CN¥683.59 Million | CN¥151.21 Million | 0.221x | -26.36% |
| 2013-12-31 | CN¥603.33 Million | CN¥181.21 Million | 0.300x | -10.59% |
| 2012-12-31 | CN¥440.47 Million | CN¥147.96 Million | 0.336x | -31.46% |
| 2011-12-31 | CN¥311.26 Million | CN¥152.54 Million | 0.490x | +35.24% |
| 2010-12-31 | CN¥195.88 Million | CN¥70.98 Million | 0.362x | -- |